Gupta, Anjali
Omeogu, Chioma
Islam, Jessica Y.
Joshi, Ashwini
Zhang, Dongyu
Braithwaite, Dejana
Karanth, Shama D.
Tailor, Tina D.
Clarke, Jeffrey M.
Akinyemiju, Tomi
Article History
Received: 22 November 2022
Accepted: 15 May 2023
First Online: 20 May 2023
Competing interests
: Dr. Clarke reports grants from Bristol-Myers Squibb, grants and personal fees from Genentech, grants and personal fees from Spectrum, grants from Adaptimmune, grants from Medpacto, grants from Bayer, grants from AbbVie, grants from Moderna, grants from GlaxoSmithKline, grants from Array, grants, personal fees and non-financial support from AstraZeneca, grants from Grid Therapeutics, grants from CBMG, personal fees from Guardant, personal fees and non-financial support from Merck, personal fees and non-financial support from Pfizer, personal fees and non-financial support from NGM Biopharmaceuticals, other from G1 Therapeutics, other from Lung Cancer Initiative of North Carolina, outside the submitted work. Dongyu Zhang is currently an employee of Johnson & Johnson, but he was affiliated with the University of Florida during the conduct of the study; therefore he has no conflict of interest. All other authors declare no conflicts of interest.